Synthesis and decoding of selenocysteine and human health

Croatian Medical Journal

Volumn 53, Issue 6, 2012, Pages 535-550

  Schmidt, Rachel L ^a   Simonović, Miljan ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; MEMBRANE PROTEIN; MESSENGER RNA; METHIONINE SULFOXIDE REDUCTASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; POLYPEPTIDE; SELENIUM; SELENOCYSTEINE; SELENOPROTEIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; TRANSFER RNA;

AMINO ACID SYNTHESIS; BRAIN ATROPHY; CATABOLISM; CEREBELLUM ATROPHY; CODON; DIET SUPPLEMENTATION; GENE INSERTION; GENE MUTATION; GENETIC CODE; HEALTH STATUS; HOMEOSTASIS; HUMAN; METABOLIC RATE; METABOLIC REGULATION; MOLECULAR MECHANICS; NONHUMAN; POINT MUTATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SURVIVAL;

EID: 84872774675     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.535     Document Type: Review

References (110)

1. Klaproth MH. Chemical examination of the Transylvanian gold ores, collection of German papers, which were read aloud at the Royal Academy of Sciences in Berlin in the years 1789-1800 [in German].
2. Berzelius JJ. Letter from Berthollet Berzelius M on two new metals [in French]. Annales de Chimie et de Physique, Série 2. 1818;7:199-202.
3. Amor AJ, Pringle P. A review of selenium as an industrial hazard. Bull Hyg (Lond). 1945;20:239-41.
4. Dudley HC. Selenium as a potential industrial hazard. Public Health Rep. 1938;53:281-92
5. Painter EP. The chemistry and toxicity of selenium compounds, with special reference to the selnium problem. Chem Rev. 1941;28:179-213.
6. Franke KW. A new toxicant occuring naturally in certain samples of plant foodstuffs. I. Results obtained on preliminary feeding trials. J Nutr. 1934;6:597-608.
7. Gunn SA, Harr JR, Levander OA, Olson OE, Schroeder HJ, Allaway WH, et al. Medical and biological effects of environmental pollutants, selenium. Washington (D.C.): National Academy of Sciences; 1976.
8. Franke KW, Moxon AL, Polley WE, Tully WC. A new toxicant occuring naturally in certain samples of plant foodstuffs. XII. Monstrosities produced by the injection of selenium salts into hen's eggs. Anat Rec. 1936;65:15-22.
9. Tarantal AF, Willhite CC, Lasley BL, Murphy CJ, Miller CJ, Cukierski MJ, et al. Developmental toxicity of L-selenomethionine in Macaca fascicularis. Fundam Appl Toxicol. 1991;16:147-60.
10. Robertson DS. Selenium-a possible teratogen? Lancet. 1970;1:518-9.
11. Nelson AA, Fitzhugh OG, Calvery HO. Liver tumors following cirrhosis caused by selenium in rats. Cancer Res. 1943;3:230-6.
12. Pinsent J. The need for selenite and molybdate in the formation of formic dehydrogenase by members of the coli-aerogenes group of bacteria. Biochem J. 1954;57:10-6.
13. Schwarz K, Foltz CM. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc. 1957;79:3292-3.
14. Muth OH, Oldfield JE, Remmert LF, Schubert JR. Effects of selenium and vitamin E on white muscle disease. Science. 1958;128:1090.
15. Oldfield JE, Ellis WW, Muth OH. White muscle disease (myopathy) in lambs and calves. III. Experimental production in calves from cows fed alfalfa hay. J Am Vet Med Assoc. 1958;132:211-4.
16. Patterson EL, Milstrey R, Stokstad EL. Effect of selenium in preventing exudative diathesis in chicks. Proc Soc Exp Biol Med. 1957;95:617-20.
17. Schwarz K, Bieri JG, Briggs GM, Scott ML. Prevention of exudative diathesis in chicks by factor 3 and selenium. Proc Soc Exp Biol Med. 1957;95:621-5.
18. Gunn SA, Gould TC, Anderson WA. Incorporation of selenium into spermatogenic pathway in mice. Proc Soc Exp Biol Med. 1967;124:1260-3.
19. Brown DG, Burk RF. Selenium retention in tissues and sperm of rats fed a Torula yeast diet. J Nutr. 1973;103:102-8.
20. Wu SH, Oldfield JE, Whanger PD, Weswig PH. Effect of selenium, vitamin E, and antioxidants on testicular function in rats. Biol Reprod. 1973;8:625-9.
21. Van Vleet JF, Carlton W, Olander HJ. Hepatosis dietetica and mulberry heart disease associated with selenium deficiency in Indiana swine. J Am Vet Med Assoc. 1970;157:1208-19.
22. Keshan Disease Research Group. Observations on effect of sodium selenite in prevention of Keshan disease. Chin Med J (Engl). 1979;92:471-6.
23. Frost DV. The two faces of selenium-can selenophobia be cured? CRC Crit Rev Toxicol. 1972;1:467-514.
24. Yang GQ, Ge KY, Chen JS, Chen XS. Selenium-related endemic diseases and the daily selenium requirement of humans. World Rev Nutr Diet. 1988;55:98-152.
25. Vanderpas JB, Contempre B, Duale NL, Goossens W, Bebe N, Thorpe R, et al. Iodine and selenium deficiency associated with cretinism in northern Zaire. Am J Clin Nutr. 1990;52:1087-93.
26. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588-90.
27. Flohe L, Gunzler WA, Schock HH. Glutathione peroxidase: a selenoenzyme. FEBS Lett. 1973;32:132-4.
28. Oh SH, Ganther HE, Hoekstra WG. Selenium as a component of glutathione periodase isolated from ovine erythrocytes. Biochemistry. 1974;13:1825-9.
29. Nakamura W, Hosoda S, Hayashi K. Purification and properties of rat liver glutathione peroxidase. Biochim Biophys Acta. 1974;358:251-61.
30. Awasthi YC, Beutler E, Srivastava SK. Purification and properties of human erythrocyte glutathione peroxidase. J Biol Chem. 1975;250:5144-9.
31. Awasthi YC, Dao DD, Lal AK, Srivastava SK. Purification and properties of glutathione peroxidase from human placenta. Biochem J. 1979;177:471-6.
32. Bell JG, Cowey CB, Youngson A. Rainbow trout liver microsomal lipid peroxidation. The effect of purified glutathione peroxidase, glutathione S-transferase and other factors. Biochim Biophys Acta. 1984;795:91-9.
33. Turner DC, Stadtman TC. Purification of protein components of the clostridial glycine reductase system and characterization of protein A as a selenoprotein. Arch Biochem Biophys. 1973;154:366-81.
34. Andreesen JR, Ljungdahl LG. Formate dehydrogenase of Clostridium thermoaceticum: incorporation of selenium-75, and the effects of selenite, molybdate, and tungstate on the enzyme. J Bacteriol. 1973;116:867-73.
35. Cox JC, Edwards ES, DeMoss JA. Resolution of distinct seleniumcontaining formate dehydrogenases from Escherichia coli. J Bacteriol. 1981;145:1317-24.
36. Stadtman TC. Selenium-dependent enzymes. Annu Rev Biochem. 1980;49:93-110.
37. Cone JE, Del Rio RM, Davis JN, Stadtman TC. Chemical characterization of the selenoprotein component of clostridial glycine reductase: identification of selenocysteine as the organoselenium moiety. Proc Natl Acad Sci U S A. 1976;73:2659-63.
38. Forstrom JW, Zakowski JJ, Tappel AL. Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry. 1978;17:2639-44.
39. Wendel A, Kerner B, Graupe K. The selenium moeity of gluatathione peroxidase. Hoppe Seylers Z Physiol Chem. 1978;359:1035-6.
40. Wendel A, Pilz W, Ladenstein R, Sawatzki G, Weser U. Substrateinduced redox change of selenium in glutathione peroxidase studied by x-ray photoelectron spectroscopy. Biochim Biophys Acta. 1975;377:211-5.
41. Ladenstein R, Epp O, Bartels K, Jones A, Huber R, Wendel A. Structure analysis and molecular model of the selenoenzyme glutathione peroxidase at 2.8 A resolution. J Mol Biol. 1979;134:199-218.
42. Gunzler WA, Steffens GJ, Grossmann A, Kim SM, Otting F, Wendel A, et al. The amino-acid sequence of bovine glutathione peroxidase. Hoppe Seylers Z Physiol Chem. 1984;365:195-212.
43. Mullenbach GT, Tabrizi A, Irvine BD, Bell GI, Tainer JA, Hallewell RA. Selenocysteine's mechanism of incorporation and evolution revealed in cDNAs of three glutathione peroxidases. Protein Eng. 1988;2:239-46.
44. Chambers I, Frampton J, Goldfarb P, Affara N, McBain W, Harrison PR. The structure of the mouse glutathione peroxidase gene: the selenocysteine in the active site is encoded by the 'termination' codon, TGA. EMBO J. 1986;5:1221-7.
45. Zinoni F, Birkmann A, Stadtman TC, Böck A. Nucleotide sequence and expression of the selenocysteine-containing polypeptide of formate dehydrogenase (formate-hydrogen-lyase-linked) from Escherichia coli. Proc Natl Acad Sci U S A. 1986;83:4650-4.
46. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, et al. Characterization of mammalian selenoproteomes. Science. 2003;300:1439-43.
47. Bösl MR, Takaku K, Oshima M, Nishimura S, Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci U S A. 1997;94:5531-4.
48. Leinfelder W, Forchhammer K, Zinoni F, Sawers G, Mandrand-Berthelot MA, Bock A. Escherichia coli genes whose products are involved in selenium metabolism. J Bacteriol. 1988;170:540-6.
49. Palioura S, Sherrer RL, Steitz TA, Söll D, Simonović M. The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation. Science. 2009;325:321-5.
50. Itoh Y, Chiba S, Sekine S, Yokoyama S. Crystal structure of human selenocysteine tRNA. Nucleic Acids Res. 2009;37:6259-68.
51. Chiba S, Itoh Y, Sekine S, Yokoyama S. Structural basis for the major role of O-phosphoseryl-tRNA kinase in the UGA-specific encoding of selenocysteine. Mol Cell. 2010;39:410-20.
52. Biou V, Yaremchuk A, Tukalo M, Cusack S. The 2.9 A crystal structure of T. thermophilus seryl-tRNA synthetase complexed with tRNA(Ser). Science. 1994;263:1404-10.
53. Forchhammer K, Leinfelder W, Boesmiller K, Veprek B, Böck A. Selenocysteine synthase from Escherichia coli. Nucleotide sequence of the gene (selA) and purification of the protein. J Biol Chem. 1991;266:6318-23.
54. Carlson BA, Xu XM, Kryukov GV, Rao M, Berry MJ, Gladyshev VN, et al. Identification and characterization of phosphoseryltRNA[Ser]Sec kinase. Proc Natl Acad Sci U S A. 2004;101:12848-53.
55. Sherrer RL, Ho JM, Söll D. Divergence of selenocysteine tRNA recognition by archaeal and eukaryotic O-phosphoseryl-tRNASec kinase. Nucleic Acids Res. 2008;36:1871-80.
56. Lee BJ, Worland PJ, Davis JN, Stadtman TC, Hatfield DL. Identification of a selenocysteyl-tRNA(Ser) in mammalian cells that recognizes the nonsense codon. UGA. J Biol Chem. 1989;264:9724-7.
57. Yuan J, Palioura S, Salazar JC, Su D, O'Donoghue P, Hohn MJ, et al. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci U S A. 2006;103:18923-7.
58. Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, et al. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2007;5:e4.
59. Diamond A, Dudock B, Hatfield D. Structure and properties of a bovine liver UGA suppressor serine tRNA with a tryptophan anticodon. Cell. 1981;25:497-506.
60. Hatfield D, Diamond A, Dudock B. Opal suppressor serine tRNAs from bovine liver form phosphoseryl-tRNA. Proc Natl Acad Sci U S A. 1982;79:6215-9.
61. Araiso Y, Sherrer RL, Ishitani R, Ho JM, Söll D, Nureki O. Structure of a tRNA-dependent kinase essential for selenocysteine decoding. Proc Natl Acad Sci U S A. 2009;106:16215-20.
62. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S., Meyer zum Buschenfelde KH, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet. 2000;355:1510-5.
63. Su D, Hohn MJ, Palioura S, Sherrer RL, Yuan J, Söll Soll D, et al. How an obscure archaeal gene inspired the discovery of selenocysteine biosynthesis in humans. IUBMB Life. 2009;61:35-9.
64. Palioura S, Herkel J, Simonović M, Lohse AW, Söll D. Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis. Biol Chem. 2010;391:771-6.
65. Xu XM, Carlson BA, Irons R, Mix H, Zhong N, Gladyshev VN, et al. Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem J. 2007;404:115-20.
66. Esaki N, Nakamura T, Tanaka H, Soda K. Selenocysteine lyase, a novel enzyme that specifically acts on selenocysteine. Mammalian distribution and purification and properties of pig liver enzyme. J Biol Chem. 1982;257:4386-91.
67. Forchhammer K, Leinfelder W, Bock A. Identification of a novel translation factor necessary for the incorporation of selenocysteine into protein. Nature. 1989;342:453-6.
68. Rother M, Wilting R, Commans S, Böck A. Identification and characterisation of the selenocysteine-specific translation factor SelB from the archaeon Methanococcus jannaschii. J Mol Biol. 2000;299:351-8.
69. Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney JW, Driscoll D, et al. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 2000;1:158-63.
70. Fagegaltier D, Hubert N, Yamada K, Mizutani T, Carbon P, Krol A. Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J. 2000;19:4796-805.
71. Zinoni F, Heider J, Böck A. Features of the formate dehydrogenase mRNA necessary for decoding of the UGA codon as selenocysteine. Proc Natl Acad Sci U S A. 1990;87:4660-4.
72. Leibundgut M, Frick C, Thanbichler M, Böck A, Ban N. Selenocysteine tRNA-specific elongation factor SelB is a structural chimaera of elongation and initiation factors. EMBO J. 2005;24:11-22.
73. Rother M, Resch A, Wilting R, Böck A. Selenoprotein synthesis in archaea. Biofactors. 2001;14:75-83.
74. Wilting R, Schorling S, Persson BC, Böck A. Selenoprotein synthesis in archaea: identification of an mRNA element of Methanococcus jannaschii probably directing selenocysteine insertion. J Mol Biol. 1997;266:637-41.
75. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, et al. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Nature. 1991;353:273-6.
76. Shen Q, Chu FF, Newburger PE. Sequences in the 3'-untranslated region of the human cellular glutathione peroxidase gene are necessary and sufficient for selenocysteine incorporation at the UGA codon. J Biol Chem. 1993;268:11463-9.
77. Shchedrina VA, Novoselov SV, Malinouski MY, Gladyshev VN. Identification and characterization of a selenoprotein family containing a diselenide bond in a redox motif. Proc Natl Acad Sci U S A. 2007;104:13919-24.
78. Krol A. Evolutionarily different RNA motifs and RNA-protein complexes to achieve selenoprotein synthesis. Biochimie. 2002;84:765-74.
79. Budiman ME, Bubenik JL, Miniard AC, Middleton LM, Gerber CA, Cash A, et al. Eukaryotic initiation factor 4a3 is a seleniumregulated RNA-binding protein that selectively inhibits selenocysteine incorporation. Mol Cell. 2009;35:479-89.
80. Copeland PR, Driscoll DM. Purification, redox sensitivity, and RNA binding properties of SECIS-binding protein 2, a protein involved in selenoprotein biosynthesis. J Biol Chem. 1999;274:25447-54.
81. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, Driscoll DM. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J. 2000;19:306-14.
82. Olieric V, Wolff P, Takeuchi A, Bec G, Birck C, Vitorino M, et al. SECIS-binding protein 2, a key player in selenoprotein synthesis, is an intrinsically disordered protein. Biochimie. 2009;91:1003-9.
83. Donovan J, Copeland PR. Evolutionary history of selenocysteine incorporation from the perspective of SECIS binding proteins. BMC Evol Biol. 2009;9:229.
84. Donovan J, Copeland PR. Selenocysteine insertion sequence binding protein 2L is implicated as a novel post-transcriptional regulator of selenoprotein expression. PLoS ONE. 2012;7:e35581.
85. Caban K, Kinzy SA, Copeland PR. The L7Ae RNA binding motif is a multifunctional domain required for the ribosome-dependent Sec incorporation activity of Sec insertion sequence binding protein 2. Mol Cell Biol. 2007;27:6350-60.
86. Copeland PR, Stepanik VA, Driscoll DM. Insight into mammalian selenocysteine insertion: domain structure and ribosome binding properties of Sec insertion sequence binding protein 2. Mol Cell Biol. 2001;21:1491-8.
87. C aban K, Copeland PR. Selenocysteine insertion sequence (SECIS)-binding protein 2 alters conformational dynamics of residues involved in tRNA accommodation in 80 S ribosomes. J Biol Chem. 2012;287:10664-73.
88. Donovan J, Caban K, Ranaweera R, Gonzalez-Flores JN, Copeland PR. A novel protein domain induces high affinity selenocysteine insertion sequence binding and elongation factor recruitment. J Biol Chem. 2008;283:35129-39.
89. Gonzales-Flores JN, Gupta N, DeMong LW, Copeland PR. The selenocysteine-specific elongation factor contains a novel and multi-functional domain. J Biol Chem. 2012;287:38936-45.
90. Howard MT, Aggarwal G, Anderson CB, Khatri S, Flanigan KM, Atkins JF. Recoding elements located adjacent to a subset of eukaryal selenocysteine-specifying UGA codons. EMBO J. 2005;24:1596-607.
91. Howard MT, Moyle MW, Aggarwal G, Carlson BA, Anderson CB. A recoding element that stimulates decoding of UGA codons by Sec tRNA[Ser]Sec. RNA. 2007;13:912-20.
92. Maiti B, Arbogast S, Allamand V, Moyle MW, Anderson CB, Richard P, et al. A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy. Hum Mutat. 2009;30:411-6.
93. Rayman MP. Selenium and human health. Lancet. 2012;379:1256-68.
94. Agamy O, Ben Zeev B, Lev D, Marcus B, Fine D, Su D, et al. Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy. Am J Hum Genet. 2010;87:538-44.
95. Hill KE, Zhou J, McMahan WJ, Motley AK, Atkins JF, Gesteland RF, et al. Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem. 2003;278:13640-6.
96. Burk RF, Hill KE, Olson GE, Weeber EJ, Motley AK, Winfrey VP, et al. Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J Neurosci. 2007;27:6207-11.
97. H ill KE, Zhou J, McMahan WJ, Motley AK, Burk RF. Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J Nutr. 2004;134:157-61.
98. Valentine WM, Abel TW, Hill KE, Austin LM, Burk RF. Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. J Neuropathol Exp Neurol. 2008;67:68-77.
99. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, et al. Neuronal selenoprotein expression is required for interneuron development and prevents sei,ures and neurodegeneration. FA SEB J. 2010;24:844-52.
100. Dumitrescu AM, Liao XH, Abdullah MS, Lado-Abeal J, Majed FA, Moeller LC, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet. 2005;37:1247-52.
101. Bianco AC, Larsen PR. Cellular and structural biology of the deiodinases. Thyroid. 2005;15:777-86.
102. Bubenik JL, Driscoll DM. Altered RNA binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in selenocysteine insertion sequence-binding protein 2. J Biol Chem. 2007;282:34653-62.
103. Squires JE, Stoytchev I, Forry EP, Berry MJ. SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay. Mol Cell Biol. 2007;27:7848-55.
104. Di Cosmo C, McLellan N, Liao XH, Khanna KK, Weiss RE, Papp L, et al. Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J Clin Endocrinol Metab. 2009;94:4003-9.
105. Hamajima T, Mushimoto Y, Kobayashi H, Saito Y, Onigata K. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur J Endocrinol. 2012;166:757-64.
106. A zevedo MF, Barra GB, Naves LA, Ribeiro Velasco LF, Godoy Garcia Castro P, de Castro LC, et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab. 2010;95:4066-71.
107. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest. 2010;120:4220-35.
108. Gladyshev VN, Jeang KT, Wootton JC, Hatfield DL. A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J Biol Chem. 1998;273:8910-5.
109. Hu YJ, Korotkov KV, Mehta R, Hatfield DL, Rotimi CN, Luke A, et al. Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene. Cancer Res. 2001;61:2307-10.
110. Allamand V, Richard P, Lescure A, Ledeuil C, Desjardin D, Petit N, et al. A single homozygous point mutation in a 3'-untranslated region motif of selenoprotein N mRNA causes SEPN1-related myopathy. EMBO Rep. 2006;7:450-4.